On tonight’s MAD MONEY on CNBC, Jim Cramer came out calling for a move toward being ultra-defensive in what he said is a bear market and fed-mandated recession (here’s our own 2008 defensive stocks…
Dendreon Corp. (NASDAQ:DNDN) shares are trading up in early trading on a patent award, and that is after the fairly large gains yesterday. Dendreon was granted a broad European patent covering what is still…
On tonight’s MAD MONEY on CNBC, Jim Cramer came out with a positive tease early on in the contract research organization sector (CRO’s) as it pertains to drugs, biotech, and medical research. He thinks…
Genentech (NYSE: DNA) just announced its earnings were $0.69 EPS on $2.96 billion for the last quarter, and First Call had estimates pegged at $0.67 EPS on revenues of $2.97 Billion. The company has…
Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company’s news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke disappointed the market a little over…
Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion. This will also mark the end of the fiscal…
Getting high on cold mediciation appears to have become the "hot" path to a good time. And, it’s inexpensive and unregulated. Procter & Gamble’s (PG) NyQuil is now being headlined in the press as…
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Genzyme Corp. (NASDAQ: GENZ) have entered into a major strategic alliance in which Genzyme will develop and commercialize mipomersen. Mipomersen is Isis’ potential blockbuster lipid-lowering treatment for high…
Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs haven’t been immune. You can even see that the Biotech HOLDRs (BBH) at $160+…
Becton, Dickinson & Co. (NYSE: BDX) is seeing shares hitting new all-time highs as it has received clearance from the U.S. FDA for the BD GeneOhm(TM) StaphSR assay. This is BD Diagnostic’s new assay…
Genitope Corp. (NASDAQ:GTOP) probably just made sure the workers’ kids won’t be getting much more than coal this year. Genitope announced that its pivotal Phase 3 clinical trial examining the use of MyVax® personalized…
Medarex, Inc. (NASDAQ: MEDX) has announced that it will receive a milestone payment from Amgen (NASDAQ: AMGN). Unfortunately, Medarex said the amount is for an undisclosed sum for advancing an antibody into human clinical…
On tonight’s MAD MONEY on CNBC, Jim Cramer said he wanted to review some picks that you might want to own with a 5-year time horizon for the future. He wants to look beyond…
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to watch for…
For Boston Scientific (BSX) the news gets worse every day. The FDA says it will set up new guidelines for testing stents, which is one of BSX’s largest businesses. According to The Wall Street…